Literature DB >> 20393276

Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.

Berthold Koletzko1, Olivier Goulet.   

Abstract

PURPOSE OF REVIEW: Lipid emulsions containing fish oils have been proposed to improve parenteral nutrition associated cholestasis (PNAC), a very serious complication of prolonged parenteral nutrition occurring particularly in infants and children with intestinal failure. Here, we summarize current data. RECENT
FINDINGS: The cause of PNAC is multifactorial. Prevention is possible by appropriate management, surgical procedures, infection prevention, and optimal parenteral nutrition management. Plausible hypotheses and experimental data support potential benefits of fish oils for treatment and prevention of PNAC. Improvement of PNAC over weeks and months has been reported in observational case studies in part of the children who received parenteral lipids with fish oil, but similar improvements also occurred by withholding or reducing standard lipid emulsions. No controlled trials are available that would allow final conclusions on efficacy and safety of fish oil-based emulsions in PNAC. Concerns exist regarding possible untoward effects and an inadequate supply of n-6 fatty acids with parenteral fish oil only. First data from controlled trials with mixed lipid emulsions containing partly fish oil suggest safety in infants and children and some possible benefits for liver function.
SUMMARY: The observed improvement of PNAC on parenteral lipids with fish oil deserves further exploration. No controlled trials are available, nutritional adequacy and safety of 100% fish oil emulsions are not adequately documented, and currently their use cannot be considered standard care. First data on mixed lipid emulsions with some fish oil are encouraging, and their effects in PNAC should also be explored.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393276     DOI: 10.1097/MCO.0b013e3283385407

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  19 in total

Review 1.  Chronic intestinal failure in children.

Authors:  Michael B Krawinkel; Dietmar Scholz; Andreas Busch; Martina Kohl; Lukas M Wessel; Klaus-Peter Zimmer
Journal:  Dtsch Arztebl Int       Date:  2012-06-04       Impact factor: 5.594

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

3.  Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats.

Authors:  Yu-Dong Qiu; Sheng Wang; Yue Yang; Xiao-Peng Yan
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

4.  Comparison of liver function with two new/mixed intravenous lipid emulsions in children with intestinal failure.

Authors:  J Pichler; V Simchowitz; S Macdonald; S Hill
Journal:  Eur J Clin Nutr       Date:  2014-06-25       Impact factor: 4.016

5.  Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats.

Authors:  Chih-Cheng Chen; Chun-Yi Ho; Hsio-Chi Chaung; You-Lin Tain; Chih-Sung Hsieh; Fang-Ying Kuo; Chun-Yu Yang; Li-Tung Huang
Journal:  Dig Dis Sci       Date:  2012-12-01       Impact factor: 3.199

6.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016

7.  Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Padade M Vue; Wujuan Zhang; Kenneth D R Setchell; Saul J Karpen; Ronald J Sokol
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

Review 8.  Complications associated with parenteral nutrition in the neonate.

Authors:  Kara L Calkins; Robert S Venick; Sherin U Devaskar
Journal:  Clin Perinatol       Date:  2014-06       Impact factor: 3.430

9.  Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.

Authors:  Marianne Skytte Jakobsen; Marianne Hørby Jørgensen; Steffen Husby; Leis Andersen; Palle Bekker Jeppesen
Journal:  Dig Dis Sci       Date:  2014-08-09       Impact factor: 3.199

Review 10.  Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants.

Authors:  Vishal Kapoor; Rebecca Glover; Manoj N Malviya
Journal:  Cochrane Database Syst Rev       Date:  2015-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.